(ANSA) - WASHINGTON, APRIL 29 - The American Food and Drugs Administration is ready to authorize the use of the experimental drug remdesivir to treat patients with coronavirus in emergencies. The antiviral produced by the American company Gilead Science has been tested on a group of people infected by Covid-19 and has given good results, speeding up healing times by 31%, explains the American Health Institute.
Use ready to authorize remdesivir use
2020-04-29T19:24:05.120Z
The American Food and Drugs Administration is ready to authorize the use of the experimental drug remdesivir in emergency to treat patients with coronavirus. (HANDLE)